Description
Recombinant Human CLDN1/Claudin-1 Protein-VLP
|
Name |
Cat# |
Size |
|
Recombinant Human CLDN1/Claudin-1 Protein-VLP |
95039ES60 |
100 μg |
|
95039ES80 |
1 mg |
Product Properties
|
Synonyms |
CLD1, ILVASC, SEMP1 |
|
Source |
HEK293 Cells |
|
AA sequence |
Accession #O95832: Met1 - Val211 |
|
Endotoxin |
< 1EU per μg by the LAL method. |
|
Purity |
>90% as determined by DLS. |
|
Formulation |
115mM Gly 4% trehalose |
|
Activity |
ELISA Data 1：Immobilized Human CLDN1 VLP at 5 ug/mL (30 uL/well) can bind Monoclonal Anti-Human CLDN1 antibody, The EC50 was approximately 0.07513 ug/ml. |
|
Applications |
ELISA, BLI, SPR, Immunization |
|
Dilution |
Dilute with PBS. |
Figure
Figure 1. Immobilized Human CLDN1 VLP at 5 ug/mL (30 uL/well) can bind Monoclonal Anti-Human CLDN1 antibody, The EC50 was approximately 0.07513 ug/ml.
Storage
The product should be stored at -85~-65℃ for 1 year from date of receipt.
Recommend to aliquot the protein into smaller quantities when first used and avoid repeated freeze-thaw cycles.
Cautions
- Please operate with lab coats and disposable gloves,for your safety.
- This product is for research use only.
Payment & Security
Your payment information is processed securely. We do not store credit card details nor have access to your credit card information.
Inquiry
You may also like
FAQ
The product is for research purposes only and is not intended for therapeutic or diagnostic use in humans or animals. Products and content are protected by patents, trademarks, and copyrights owned by Yeasen Biotechnology. Trademark symbols indicate the country of origin, not necessarily registration in all regions.
Certain applications may require additional third-party intellectual property rights.
Yeasen is dedicated to ethical science, believing our research should address critical questions while ensuring safety and ethical standards.